Royalty Pharma plc RPRX | NASDAQ
$60.07
$1.08 | 1.83%
TREND SIGNAL:
|2026-09-11
|2026-09-11
Company Overview:
Market Cap:
$26.25B
Trailing PE:
34.5x
FWD PE *:
13.1x
Payout Ratio (TTM):
48.9%
52-Week Range:
$35.79 - $64.38
* Forward PE is based on street estimates.
6.3 Year RPRX Performance Metrics:
Total Return (with DRIP):
54.9% (7.19% CAGR)
Total Return (no DRIP):
46.1% (6.21% CAGR)
Share Price:
35.0% (4.88% CAGR)
Yield on Cost (with DRIP):
2.42%
Total Invested:
$10,000
Total Value (with DRIP):
$15,491
Total Return $ (with DRIP):
$5,491
Dividend Increase:
56.7% (7.89% CAGR)
Dividend Yield (FWD):
1.56% ($0.94)
RPRX 6.3-yr Total Return ($10K invested)
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
RPRX Share Price
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
All
RPRX Price CAGR:1Y: 66.03%2Y: 46.89%5Y: 9.37%10Y: 4.85%
RPRX Dividend Charts
RPRX Dividend CAGR:1Y: 6.82%2Y: 5.79%5Y: 6.69%10Y: 7.89%
RPRX Dividend Payout Ratio CAGR:1Y: 89.87%2Y: 151.06%5Y: 104.34%10Y: 0.00%
RPRX Dividend to FCF Ratio CAGR:1Y: -40.31%2Y: 2.96%5Y: 2.30%10Y: 0.00%
Unlock All Reports & Research Dividend Stocks like a BOSS!
Get 3 Months Free with Annual Plan
Get 3 Months Free with Annual Plan
PRO
$19/mo
$11.40/mo
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
40% Lifetime Discount
Most Popular
PREMIUM
$32/mo
$19.20/mo
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
40% Lifetime Discount
ULTRA
$64/mo
$38.40/mo
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
40% Lifetime Discount
PRO
$171 ($14.25/mo)
$102.60/yr ($8.55/mo)
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo)
$172.80/yr ($14.40/mo)
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo)
$345.60/yr ($28.80/mo)
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
Combined 55% Lifetime Discount
RPRX Financials: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:
RPRX Revenue CAGR:1Y: 16.50%2Y: 12.02%5Y: 3.97%10Y: 0.00%
RPRX EPS CAGR:1Y: -42.86%2Y: -58.30%5Y: -48.27%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
RPRX Net Income CAGR:1Y: -40.74%2Y: -58.13%5Y: -47.32%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
RPRX EBITDA CAGR:1Y: 10.73%2Y: -14.87%5Y: -26.98%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
RPRX Free Cash Flow CAGR:1Y: 88.51%2Y: 2.10%5Y: 5.23%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
RPRX Free Cash Flow / Share CAGR:1Y: 79.38%2Y: 2.78%5Y: 3.49%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
RPRX Operating Income CAGR:1Y: -36.61%2Y: -29.77%5Y: -29.15%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
RPRX Gross Profit CAGR:1Y: -29.85%2Y: -13.08%5Y: -6.06%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
RPRX Shares Outstanding CAGR:1Y: -0.96%2Y: -3.41%5Y: -1.71%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
RPRX Share Buybacks CAGR:1Y: -84.69%2Y: -25.30%5Y: 0.00%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
RPRX Stock-Based Comp CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
RPRX Expenses CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
🔓 See the full chart40% off right now · 7-day free trial
🔓 See the full chart40% off right now · 7-day free trial
🔓 See the full chart40% off right now · 7-day free trial
🔓 See the full chart40% off right now · 7-day free trial
🔓 See the full chart40% off right now · 7-day free trial
🔓 See the full chart40% off right now · 7-day free trial
RPRX Revenue CAGR:1Y: 16.50%2Y: 12.02%5Y: 3.97%10Y: 0.00%
Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:
🔓 See the full chart40% off right now · 7-day free trial
RPRX Actual Revenue CAGR:1Y: 16.50%2Y: 12.02%5Y: 3.97%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
RPRX Actual EPS CAGR:1Y: -42.86%2Y: -58.30%5Y: -48.27%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
RPRX Actual Net Income CAGR:1Y: -40.74%2Y: -58.13%5Y: -47.32%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
RPRX Actual EBITDA CAGR:1Y: 10.73%2Y: -14.87%5Y: -26.98%10Y: 0.00%
Ratios, Profit Margins & Return on Capital:
🔓 See the full chart40% off right now · 7-day free trial
RPRX Net Profit Margin CAGR:1Y: -49.14%2Y: -62.64%5Y: -49.34%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
RPRX Gross Profit Margin CAGR:1Y: -39.79%2Y: -22.40%5Y: -9.65%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
RPRX Price to Earnings CAGR:1Y: 266.10%2Y: 250.86%5Y: 122.65%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
RPRX Price To Sales Ratio CAGR:1Y: 40.38%2Y: 29.76%5Y: 4.13%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
RPRX Return on Capital Employed CAGR:1Y: -43.45%2Y: -33.16%5Y: -31.48%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
RPRX Return on Invested Capital CAGR:1Y: -34.91%2Y: -30.29%5Y: -30.32%10Y: 0.00%
RPRX Dividends Info:
Annual Dividend:
$0.94
Forward Yield:
1.56%
Ex-Dividend Date:
2026-08-14
Lifetime Dividends / Share:
$4.97
RPRX Dividend History: Dates, Payments & Yield list
Below is a schedule of all RPRX dividend payments, ex-dates, share price on the day of the payment as well as the annualized yield & forward yield
| Ex-Date | Payment Date | Amount | Yield | Forward Yield | Price on Ex-Date |
|---|---|---|---|---|---|
| 08/14/2026 | 09/10/2026 | $0.235 | 1.6% | 1.6% | $58.75 |
| 05/15/2026 | 06/10/2026 | $0.235 | 1.78% | 1.72% | $54.52 |
| 02/20/2026 | 03/10/2026 | $0.235 | 2.08% | 2.04% | $45.97 |
| 11/14/2025 | 12/10/2025 | $0.220 | 2.25% | 2.3% | $38.26 |
| 08/15/2025 | 09/10/2025 | $0.220 | 2.42% | 2.43% | $36.18 |
| 05/16/2025 | 06/10/2025 | $0.220 | 2.59% | 2.62% | $33.58 |
| 02/21/2025 | 03/10/2025 | $0.220 | 2.63% | 2.69% | $32.75 |
| 11/15/2024 | 12/10/2024 | $0.210 | 3.27% | 3.28% | $25.59 |
| 08/16/2024 | 09/13/2024 | $0.210 | 3.09% | 3.03% | $27.72 |
| 05/16/2024 | 06/14/2024 | $0.210 | 3.01% | 3.12% | $26.92 |
| 02/15/2024 | 03/15/2024 | $0.210 | 2.8% | 2.79% | $30.09 |
| 11/16/2023 | 12/15/2023 | $0.200 | 3.02% | 2.92% | $27.37 |
| 08/17/2023 | 09/15/2023 | $0.200 | 2.73% | 2.84% | $28.13 |
| 05/18/2023 | 06/15/2023 | $0.200 | 2.38% | 2.48% | $32.20 |
| 02/15/2023 | 03/15/2023 | $0.200 | 2.12% | 2.32% | $34.50 |
| 11/17/2022 | 12/15/2022 | $0.190 | 1.8% | 1.86% | $40.79 |
| 08/18/2022 | 09/15/2022 | $0.190 | 1.72% | 1.8% | $42.17 |
| 05/19/2022 | 06/15/2022 | $0.190 | 1.91% | 1.97% | $38.53 |
| 02/17/2022 | 03/15/2022 | $0.190 | 1.92% | 1.99% | $38.27 |
| 11/18/2021 | 12/15/2021 | $0.170 | 1.62% | 1.81% | $37.52 |
| 08/19/2021 | 09/15/2021 | $0.170 | 1.75% | 1.79% | $37.97 |
| 05/19/2021 | 06/15/2021 | $0.170 | 1.7% | 1.54% | $44.02 |
| 02/18/2021 | 03/15/2021 | $0.170 | 1.46% | 1.45% | $46.84 |
| 11/19/2020 | 12/15/2020 | $0.150 | 1.45% | 1.37% | $43.85 |
| 09/14/2020 | 09/30/2020 | $0.150 | 1.51% | 1.43% | $42.07 |
Projected Future Returns & Dividends for RPRX
Based on past 6.3-year performance, here are RPRX growth metrics:
Share price CAGR of +4.88%
Dividend CAGR of +7.85%
Using RPRX CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:
| RPRX (DRIP) | RPRX - No DRIP | |
|---|---|---|
| Current Price | $60.07 | $60.07 |
| Start Shares | 166.47 | 166.47 |
| Start Value | $10,000 | $10,000 |
| After 10 years: | ||
| Final Share Count | 198.83 | 166.47 |
| Dividends Payment | $0.50 | $0.50 |
| Annual Dividends | $398 | $333 |
| Yield on cost | 3.98% | 3.33% |
| Share Price | $96.71 | $96.71 |
| Total Dividends | $2,474 | $2,250 |
| Final Value | $19,229 | $18,350 |
Estimated Future Value + Dividends - RPRX
NOTE: Above numbers are our estimate based on RPRX's Dividend and Price CAGR over past 6.3 years.
These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.
We cannot guarantee that your actual returns will meet these estimates.
Get the best Dividend Stock Research Tools:
Get 3 Months Free with Annual Plan
Get 3 Months Free with Annual Plan
PRO
$19/mo
$11.40/mo
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
40% Lifetime Discount
Most Popular
PREMIUM
$32/mo
$19.20/mo
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
40% Lifetime Discount
ULTRA
$64/mo
$38.40/mo
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
40% Lifetime Discount
PRO
$171 ($14.25/mo)
$102.60/yr ($8.55/mo)
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo)
$172.80/yr ($14.40/mo)
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo)
$345.60/yr ($28.80/mo)
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
Combined 55% Lifetime Discount
Company Info
Royalty Pharma plc (RPRX) had its IPO on 2020-06-16, and is traded on NASDAQ stock exchange.
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
RPRX website: https://www.royaltypharma.com
Get Full Access to All Reports with DRIPCalc PRO
Get 3 Months Free with Annual Plan
Get 3 Months Free with Annual Plan
PRO
$19/mo
$11.40/mo
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
40% Lifetime Discount
Most Popular
PREMIUM
$32/mo
$19.20/mo
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
40% Lifetime Discount
ULTRA
$64/mo
$38.40/mo
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
40% Lifetime Discount
PRO
$171 ($14.25/mo)
$102.60/yr ($8.55/mo)
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo)
$172.80/yr ($14.40/mo)
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo)
$345.60/yr ($28.80/mo)
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
Combined 55% Lifetime Discount
Loading signals…
DCF Model — RPRX
Value from:
🔒 Upgrade to unlock
The full DCF valuation — fair value, implied growth and the price path — is a paid feature.
Upgrade
Pay up to today
—
vs current price $60.07
—
Cash flow & implied price by year
FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.
EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.
Free cash flow today
—
grows for the next years
Then mature
—
every future dollar counted back to today
Pile of today-dollars
—
÷ shares
Implied price path
| Year | FCF | Implied price |
|---|
Sensitivity — fair value: growth ↓ × target return →
